GTR Home > Tests > Search results - Achromatopsia 2

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1857618[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 23 tests for 1 condition in 14 labs

CCNGA3 mutation analysis

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCNGA3. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CPDE6C. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CGNAT2. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCNGB3. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAutosomal Recessive Retinitis Pigmentosa

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (58)
Total targets (57)

CAchromatopsia via the CNGA3 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAchromatopsia Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAchromatopsia 2 - CNGA3 Sequencing

Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAchromatopsia type 2

Lab: Bioarray Elche, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSingle gene testing CNGA3

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CAchromatopsia 2 (sequence analysis of CNGA3 gene)

Lab: CGC Genetics Porto, Porto, Portugal
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CRetinal Dystrophy Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (254)
Total targets (183)

CAchromatopsia Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (5)

CRetinal Dystrophy Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (254)
Total targets (183)

CCNGA3

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAchromatopsia NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)

CEye Disorders: Comprehensive Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (321)
Total targets (207)

CAchromatopsia, Cone, and Cone-rod Dystrophy: Sequencing and Deletion/Duplication Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (68)
Total targets (36)

RAchromatopsia

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (5)

Showing 1 to 20 of 23 tests for 1 condition in 14 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.